Cargando…
MyD88 in macrophages protects against colitis via inhibiting the activation of NLRP3 inflammasome in epithelial cells
Autores principales: | Liu, Shi, Wu, Yanmin, Chen, Haiqiang, Yuan, Qi, Ge, Shuang, Zhang, Lishu, Hou, Lingling, Tian, Tian, Zhang, Jinhua |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Chongqing Medical University
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10201583/ https://www.ncbi.nlm.nih.gov/pubmed/37223511 http://dx.doi.org/10.1016/j.gendis.2022.04.021 |
Ejemplares similares
-
MyD88 in Macrophages Enhances Liver Fibrosis by Activation of NLRP3 Inflammasome in HSCs
por: Ge, Shuang, et al.
Publicado: (2021) -
MyD88 in hepatic stellate cells enhances liver fibrosis via promoting macrophage M1 polarization
por: Zhang, Jie, et al.
Publicado: (2022) -
Baicalein ameliorates TNBS-induced colitis by suppressing TLR4/MyD88 signaling cascade and NLRP3 inflammasome activation in mice
por: Luo, Xiaoping, et al.
Publicado: (2017) -
Atorvastatin suppresses NLRP3 inflammasome activation in intracerebral hemorrhage via TLR4- and MyD88-dependent pathways
por: Chen, Duo, et al.
Publicado: (2022) -
Schisandrin B Attenuates Diabetic Cardiomyopathy by Targeting MyD88 and Inhibiting MyD88‐Dependent Inflammation
por: Luo, Wu, et al.
Publicado: (2022)